Schedule 13D ownership disclosure

ESPERION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 29664W105

Event date: 2015-05-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,321,842
Percent of class
16.0700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-032917
Form type
SC 13D
Filer
COLLEGIUM PHARMACEUTICAL, INC
CIK
CIK 1267565
Filed
May 21, 2015
Reporting period
May 12, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub